Investigation Overview
October 25, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Osiris Therapeutics, Inc. (NASDAQ:OSIR) shares over potential securities laws violations by Osiris Therapeutics and certain of its directors and officers in connection certain statements over its Ovation TM and Grafix was announced. The investigation by a law firm focuses on possible claims on beh...
You must register (for free) or login to view the entire investigation.